Skip to content

Advertisement

Open Peer Review Reports for: Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
20 Aug 2016 Submitted Original manuscript
1 Sep 2016 Author responded Author comments - Masatoshi Tagawa
Resubmission - Version 2
1 Sep 2016 Submitted Manuscript version 2
21 Nov 2016 Reviewed Reviewer Report - Carlos J. Ciudad
9 Feb 2017 Reviewed Reviewer Report - Frances Lennon
11 Mar 2017 Author responded Author comments - Masatoshi Tagawa
Resubmission - Version 3
11 Mar 2017 Submitted Manuscript version 3
12 Apr 2017 Author responded Author comments - Kengo Shimazu
Resubmission - Version 4
12 Apr 2017 Submitted Manuscript version 4
18 Apr 2017 Author responded Author comments - Kengo Shimazu
Resubmission - Version 5
18 Apr 2017 Submitted Manuscript version 5
Publishing
25 Apr 2017 Editorially accepted
2 May 2017 Article published 10.1186/s12885-017-3300-y

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement